Namwan, N.; Senawong, G.; Phaosiri, C.; Kumboonma, P.; Somsakeesit, L.-o.; Samankul, A.; Leerat, C.; Senawong, T.
HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells. Molecules 2022, 27, 4014.
https://doi.org/10.3390/molecules27134014
AMA Style
Namwan N, Senawong G, Phaosiri C, Kumboonma P, Somsakeesit L-o, Samankul A, Leerat C, Senawong T.
HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells. Molecules. 2022; 27(13):4014.
https://doi.org/10.3390/molecules27134014
Chicago/Turabian Style
Namwan, Narissara, Gulsiri Senawong, Chanokbhorn Phaosiri, Pakit Kumboonma, La-or Somsakeesit, Arunta Samankul, Chadaporn Leerat, and Thanaset Senawong.
2022. "HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells" Molecules 27, no. 13: 4014.
https://doi.org/10.3390/molecules27134014
APA Style
Namwan, N., Senawong, G., Phaosiri, C., Kumboonma, P., Somsakeesit, L.-o., Samankul, A., Leerat, C., & Senawong, T.
(2022). HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells. Molecules, 27(13), 4014.
https://doi.org/10.3390/molecules27134014